10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide

C138H124Ir4N11O4-6 — CID 157130331

IUPAC10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide
SMILESCN1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.[Ir+3].[Ir].[Ir].[Ir].[c-]1cccc2ccc3cccnc3c12.[c-]1ccccc1-c1ccccn1.c1ccc(-c2nc3ccccc3[n-]2)nc1
InChIInChI=1S/4C22H22NO.C14H12N2.C13H8N.C12H8N3.C11H8N.4Ir/c4*1-13(2)8-16-6-5-7-20-17(16)11-21-22(23-20)18-10-14(3)9-15(4)19(18)12-24-21;1-15-11-16(12-7-3-2-4-8-12)14-10-6-5-9-13(14)15;1-2-6-12-10(4-1)7-8-11-5-3-9-14-13(11)12;1-2-6-10-9(5-1)14-12(15-10)11-7-3-4-8-13-11;1-2-6-10(7-3-1)11-8-4-5-9-12-11;;;;/h4*5-7,9,11,13H,8,12H2,1-4H3;2-7,9-11H,1H3;1-5,7-9H;1-8H;1-6,8-9H;;;;/q4*-1;-2;3*-1;;;;+3
InChIKeyXKVGRQYWZFKBTB-UHFFFAOYSA-N
MW2769.45 g/mol
LogP32.81
Rot. Bonds11

About 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide

10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide (PubChem CID 157130331) has the molecular formula C138H124Ir4N11O4-6 and a molecular weight of 2769.45 g/mol. Its IUPAC name is 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide.

Molecular Properties

Compound Name10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide
PubChem CID157130331
Molecular FormulaC138H124Ir4N11O4-6
Molecular Weight2769.45 g/mol
Exact Mass2770.84
IUPAC Name10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide
SMILESCN1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.[Ir+3].[Ir].[Ir].[Ir].[c-]1cccc2ccc3cccnc3c12.[c-]1ccccc1-c1ccccn1.c1ccc(-c2nc3ccccc3[n-]2)nc1
InChIInChI=1S/4C22H22NO.C14H12N2.C13H8N.C12H8N3.C11H8N.4Ir/c4*1-13(2)8-16-6-5-7-20-17(16)11-21-22(23-20)18-10-14(3)9-15(4)19(18)12-24-21;1-15-11-16(12-7-3-2-4-8-12)14-10-6-5-9-13(14)15;1-2-6-12-10(4-1)7-8-11-5-3-9-14-13(11)12;1-2-6-10-9(5-1)14-12(15-10)11-7-3-4-8-13-11;1-2-6-10(7-3-1)11-8-4-5-9-12-11;;;;/h4*5-7,9,11,13H,8,12H2,1-4H3;2-7,9-11H,1H3;1-5,7-9H;1-8H;1-6,8-9H;;;;/q4*-1;-2;3*-1;;;;+3
InChIKeyXKVGRQYWZFKBTB-UHFFFAOYSA-N
XLogP32.81
TPSA160.62 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds11
Heavy Atoms157
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002769.45
LogP ≤ 532.81
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide?
The IUPAC name of 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide (CID 157130331) is 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide.
What is the SMILES notation for 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide?
The canonical SMILES for 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide is CN1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.Cc1[c-]c2c(c(C)c1)COc1cc3c(CC(C)C)cccc3nc1-2.[Ir+3].[Ir].[Ir].[Ir].[c-]1cccc2ccc3cccnc3c12.[c-]1ccccc1-c1ccccn1.c1ccc(-c2nc3ccccc3[n-]2)nc1.
What is the InChIKey of 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide?
The InChIKey is XKVGRQYWZFKBTB-UHFFFAOYSA-N. The full InChI is InChI=1S/4C22H22NO.C14H12N2.C13H8N.C12H8N3.C11H8N.4Ir/c4*1-13(2)8-16-6-5-7-20-17(16)11-21-22(23-20)18-10-14(3)9-15(4)19(18)12-24-21;1-15-11-16(12-7-3-2-4-8-12)14-10-6-5-9-13(14)15;1-2-6-12-10(4-1)7-8-11-5-3-9-14-13(11)12;1-2-6-10-9(5-1)14-12(15-10)11-7-3-4-8-13-11;1-2-6-10(7-3-1)11-8-4-5-9-12-11;;;;/h4*5-7,9,11,13H,8,12H2,1-4H3;2-7,9-11H,1H3;1-5,7-9H;1-8H;1-6,8-9H;;;;/q4*-1;-2;3*-1;;;;+3.
What are the key properties of 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide?
10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide has a molecular weight of 2769.45 g/mol, XLogP of 32.81, 11 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 10H-benzo[h]quinolin-10-ide;tetrakis(2,4-dimethyl-8-(2-methylpropyl)-1,5-dihydroisochromeno[4,3-b]quinolin-1-ide);tris(iridium);iridium(3+);1-methyl-3-phenyl-2H-benzimidazol-2-ide;2-phenylpyridine;2-pyridin-2-ylbenzimidazol-1-ide is sourced from PubChem (CID 157130331), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).